The DOI matches its Crossref record; 259 of the 266 references it cites were found in a registry or an index.
Unconventional microbial systems for the cost-efficient production of high-quality protein therapeutics
Abstract
Both conventional and innovative biomedical approaches require cost-effective protein drugs with high therapeutic potency, improved bioavailability, biocompatibility, stability and pharmacokinetics. The growing longevity of the human population, the increasing incidence and prevalence of age-related diseases and the better comprehension of genetic-linked disorders prompt to develop natural and engineered drugs addressed to fulfill emerging therapeutic demands. Conventional microbial systems have been for long time exploited to produce biotherapeutics, competing with animal cells due to easier operation and lower process costs. However, both biological platforms exhibit important drawbacks (mainly associated to intracellular retention of the product, lack of post-translational modifications and conformational stresses), that cannot be overcome through further strain optimization merely due to physiological constraints. The metabolic diversity among microorganisms offers a spectrum of unconventional hosts, that, being able to bypass some of these weaknesses, are under progressive incorporation into production pipelines. In this review we describe the main biological traits and potentials of emerging bacterial, yeast, fungal and microalgae systems, by comparing selected leading species with well established conventional organisms with a long run in protein drug production.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, there is evidence that the interplay of protein mutational robustness, protein folding and environmental stress is an additional key factor that determines the evolution of new traits [145,146].”
From Adaptive laboratory evolution—Principles and applications for biotechnology (2013) · cites this paper as [145]
Citations
Cites
Commercial Applications of Microalgae
Spolaore, P., Joannis-Cassan, C., Duran, E., & Isambert, A. (2006) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.101.87 · Cited by 4,285
Aggresomes: A Cellular Response to Misfolded Proteins
Johnston, J. A., Ward, C. L., & Kopito, R. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.7.1883 · Cited by 2,148
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032
Aggresomes, inclusion bodies and protein aggregation
Kopito, R. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01852-3 · Cited by 1,942
Recombinant protein folding and misfolding in Escherichia coli
Baneyx, F., & Mujacic, M. (2004) · Nature Biotechnology · doi:10.1038/nbt1029 · Cited by 1,497
Microbial Ecology: Fundamentals and Applications
Atlas, R. M., & Bartha, R. (1978) · Cited by 1,261
Protein drug stability: a formulation challenge
Frøkjær, S., & Otzen, D. E. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1695 · Cited by 1,116
Microbial Ecology: Fundamentals and Applications.
Swift, M. J., Atlas, R. M., & Bartha, R. (1982) · Journal of Ecology · doi:10.2307/2259932 · Cited by 1,113
Production of recombinant proteins by microbes and higher organisms
Demain, A. L., & Vaishnav, P. (2009) · Biotechnology Advances · doi:10.1016/j.biotechadv.2009.01.008 · Cited by 1,043
Durocher, Y. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.2.e9 · Cited by 1,037
Chloroplast Transformation in Chlamydomonas with High Velocity Microprojectiles
Boynton, J. E., Gillham, N. W., Harris, E. H., Hosler, J. P., Johnson, A. M., Jones, A. R., Randolph-Anderson, B. L., Robertson, D., Klein, T. M., Shark, K. B., et al. (1988) · Science · doi:10.1126/science.2897716 · Cited by 963
Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli
Sørensen, H. P., & Mortensen, K. K. (2005) · Microbial Cell Factories · doi:10.1186/1475-2859-4-1 · Cited by 841
The purification of eukaryotic polypeptides synthesized in Escherichia coli
Marston, F. A. O. (1986) · Biochemical Journal · doi:10.1042/bj2400001 · Cited by 837
N-Linked Glycosylation in Campylobacter jejuni and Its Functional Transfer into E. coli
Wacker, M., Linton, D., Hitchen, P. G., Lazar, M. N., Haslam, S. M., North, S. J., Panico, M., Morris, H. R., Dell, A., Wren, B. W., et al. (2002) · Science · doi:10.1126/science.298.5599.1790 · Cited by 780
Directed evolution of industrial enzymes: an update.
Cherry, J., & Fidantsef, A. (2003) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(03)00099-5 · Cited by 778
Biopharmaceutical benchmarks 2010
Walsh, G. (2010) · Nature Biotechnology · doi:10.1038/nbt0910-917 · Cited by 755
Human hepatitis B vaccine from recombinant yeast
McAleer, W. J., Buynak, E. B., Maigetter, R. Z., Wampler, D. E., Miller, W. J. W., & Hilleman, M. R. (1984) · Nature · doi:10.1038/307178a0 · Cited by 740
Microalgal biofactories: A promising approach towards sustainable omega-3 fatty acid production
Adarme-Vega, T. C., Lim, D. K. Y., Timmins, M., Vernen, F., Li, Y., & Schenk, P. M. (2012) · Microbial Cell Factories · doi:10.1186/1475-2859-11-96 · Cited by 641
A green light for engineered algae: redirecting metabolism to fuel a biotechnology revolution
Rosenberg, J. N., Oyler, G. A., Wilkinson, L., & Betenbaugh, M. J. (2008) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2008.07.008 · Cited by 631
Johnston, J. A., Dalton, M. J., Gurney, M. E., & Kopito, R. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220417997 · Cited by 616
Characterization and Dynamics of Aggresome Formation by a Cytosolic Gfp-Chimera✪
García‐Mata, R., Bebők, Z., Sorscher, E. J., & Sztul, E. S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.6.1239 · Cited by 597
Immunogenicity of protein therapeutics
Groot, A. S. D., & Scott, D. W. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.07.011 · Cited by 544
Humanization of yeast to produce complex terminally sialylated glycoproteins
Hamilton, S. R., Davidson, R. C., Sethuraman, N., Nett, J. H., Jiang, Y., Rios, S., Bobrowicz, P., Stadheim, T. A., Li, H., Choi, B.-K., et al. (2006) · Science · doi:10.1126/science.1130256 · Cited by 511
Enhancement of therapeutic protein in vivo activities through glycoengineering
Elliott, S., Lorenzini, T., Asher, S., Aoki, K., Brankow, D. W., Buck, L., Busse, L. A., Chang, D., Fuller, J., Grant, J. R., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt799 · Cited by 510
Strategies for optimizing heterologous protein expression in Escherichia coli
Hannig, G., & Makrides, S. C. (1998) · Trends in biotechnology · doi:10.1016/s0167-7799(97)01155-4 · Cited by 495
Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals
Butler, M. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-1980-8 · Cited by 493
Westers, L., Westers, H., & Quax, W. J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.02.011 · Cited by 491
Introduction to current and future protein therapeutics: A protein engineering perspective
Carter, P. J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.02.013 · Cited by 489
Recombinant protein secretion in Escherichia coli
Mergulhão, F. J. M., Summers, D. K., & Monteiro, G. A. (2005) · Biotechnology Advances · doi:10.1016/j.biotechadv.2004.11.003 · Cited by 485
Microbial factories for recombinant pharmaceuticals
Ferrer‐Miralles, N., Domingo‐Espín, J., Corchero, J. L., Vázquez, E., & Villaverde, A. (2009) · Microbial Cell Factories · doi:10.1186/1475-2859-8-17 · Cited by 465
Self-citationJanssen, M., Tramper, J., Mur, L. R., & Wijffels, R. H. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10468 · Cited by 464
Debuchy, R., Purton, S., & Rochaix, J. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08426.x · Cited by 411
Advances in the production of human therapeutic proteins in yeasts and filamentous fungi
Gerngross, T. U. (2004) · Nature Biotechnology · doi:10.1038/nbt1028 · Cited by 409
A perspective on the biotechnological potential of microalgae
Raja, R., Hemaiswarya, S., Kumar, N. A., Sridhar, S., & Rengasamy, R. (2008) · Critical Reviews in Microbiology · doi:10.1080/10408410802086783 · Cited by 404
COMMERCIAL DEVELOPMENTS IN MICROALGAL BIOTECHNOLOGY
Apt, K. E., & Behrens, P. W. (1999) · Journal of Phycology · doi:10.1046/j.1529-8817.1999.3520215.x · Cited by 402
Process economics of industrial monoclonal antibody manufacture
Farid, S. S. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.07.037 · Cited by 394
Médigue, C., Krin, E., Pascal, G., Barbe, V., Bernsel, A., Bertin, P. N., Cheung, F., Cruveiller, S., D’Amico, S., Duilio, A., et al. (2005) · Genome Research · doi:10.1101/gr.4126905 · Cited by 390
Self-citationHassles with Taking Out the Garbage: Aggravating Aggresomes
García‐Mata, R., Gao, Y., & Sztul, E. S. (2002) · Traffic · doi:10.1034/j.1600-0854.2002.30602.x · Cited by 387
Antibodies and Genetically Engineered Related Molecules: Production and Purification
Roque, A., Lowe, C. R., & Taipa, M. (2004) · Biotechnology progress (Print) · doi:10.1021/bp030070k · Cited by 368
Recombinant Protein Production in Yeasts
Mattanovich, D., Branduardi, P., Dato, L., Gasser, B., Sauer, M., & Porro, D. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-433-9_17 · Cited by 365
Self-citationProtein aggregation in recombinant bacteria: biological role of inclusion bodies
Villaverde, A., & Carrió, M. (2003) · Biotechnology Letters · doi:10.1023/a:1025024104862 · Cited by 359
Self-citationGasser, B., Saloheimo, M., Rinas, U., Dragosits, M., Rodríguez‐Carmona, E., Baumann, K., Giuliani, M., Parrilli, E., Branduardi, P., Lang, C., et al. (2008) · Microbial Cell Factories · doi:10.1186/1475-2859-7-11 · Cited by 347
Self-citationExpression and assembly of a fully active antibody in algae
Mayfield, S. P., Franklin, S. E., & Lerner, R. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237108100 · Cited by 345
Engineering of protein secretion in yeast: strategies and impact on protein production
Idiris, A., Tohda, H., Kumagai, H., & Takegawa, K. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2447-0 · Cited by 333
Formulation and manufacturability of biologics
Shire, S. J. (2009) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2009.10.006 · Cited by 331
Baldi, L., Hacker, D. L., Adam, M., & Wurm, F. M. (2007) · Biotechnology Letters · doi:10.1007/s10529-006-9297-y · Cited by 328
Therapeutic application of peptides and proteins: parenteral forever?
Antošová, Z., Macková, M., Král, V., & Macek, T. (2009) · Trends in biotechnology · doi:10.1016/j.tibtech.2009.07.009 · Cited by 325
Expression of a human gene for interferon in yeast
Hitzeman, R. A., Hagie, F. E., Levine, H. L., Goeddel, D. V., Ammerer, G., & Hall, B. D. (1981) · Nature · doi:10.1038/293717a0 · Cited by 323
Speed, M. A., Wang, D. I. C., & King, J. (1996) · Nature Biotechnology · doi:10.1038/nbt1096-1283 · Cited by 313
Vallejo, L. F., & Rinas, U. (2004) · Microbial Cell Factories · doi:10.1186/1475-2859-3-11 · Cited by 311
Micro-algae come of age as a platform for recombinant protein production
Specht, E. A., Miyake-Stoner, S. J., & Mayfield, S. P. (2010) · Biotechnology Letters · doi:10.1007/s10529-010-0326-5 · Cited by 304
Walker, T. L., Purton, S., Becker, D. K., & Collet, C. (2005) · Plant Cell Reports · doi:10.1007/s00299-005-0004-6 · Cited by 302
Genomic Diversity and Versatility of Lactobacillus plantarum, a Natural Metabolic Engineer
Siezen, R. J., & van Hylckama Vlieg, J. E. (2011) · Microbial Cell Factories · doi:10.1186/1475-2859-10-s1-s3 · Cited by 294
Chaperone-based procedure to increase yields of soluble recombinant proteins produced in E. coli
de Marco, A., Deuerling, E., Mogk, A., Tomoyasu, T., & Bukau, B. (2007) · BMC Biotechnology · doi:10.1186/1472-6750-7-32 · Cited by 291
Rathore, N., & Rajan, R. S. (2008) · Biotechnology Progress · doi:10.1021/bp070462h · Cited by 290
Delivery of peptide and protein drugs over the blood–brain barrier
Brasnjevic, I., Steinbusch, H. W. M., Schmitz, C., & Martinez-Martinez, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.12.002 · Cited by 279
Microalgae as bioreactors for bioplastic production
Hempel, F., Bozarth, A., Lindenkamp, N., Klingl, A., Zauner, S., Linne, U., Steinbüchel, A., & Maier, U. G. (2011) · Microbial Cell Factories · doi:10.1186/1475-2859-10-81 · Cited by 274
Rasala, B. A., Muto, M., Lee, P. A., Jager, M., Cardoso, R. M. F., Behnke, C. A., Kirk, P. B., Hokanson, C. A., Crea, R., Mendez, M. J., et al. (2010) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2010.00503.x · Cited by 271
Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology
Jacobs, P. P., Geysens, S., Vervecken, W., Contreras, R., & Callewaert, N. (2008) · Nature Protocols · doi:10.1038/nprot.2008.213 · Cited by 271
Nakayama, K.-I., Nagasu, T., Shimma, Y., Kuromitsu, J., & Jigami, Y. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05316.x · Cited by 260
Amyloid-like Properties of Bacterial Inclusion Bodies
Carrió, M., González‐Montalbán, N., Vera, A., Villaverde, A., & Ventura, S. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.02.030 · Cited by 254
Self-citationChallenges in therapeutic glycoprotein production
Sethuraman, N., & Stadheim, T. A. (2006) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2006.06.010 · Cited by 252
Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines
Bermúdez‐Humarán, L. G., Kharrat, P., Chatel, J., & Langella, P. (2011) · Microbial Cell Factories · doi:10.1186/1475-2859-10-s1-s4 · Cited by 244
Lactococcus lactis, an Efficient Cell Factory for Recombinant Protein Production and Secretion
Morello, E., Bermúdez‐Humarán, L. G., Llull, D., Solé-Jamault, V., Miraglio, N., Langella, P., & Poquet, I. (2007) · Microbial Physiology · doi:10.1159/000106082 · Cited by 243
Large-Scale transfection of mammalian cells for the fast production of recombinant protein
Pham, P. L., Kamen, A., & Durocher, Y. (2006) · Molecular Biotechnology · doi:10.1385/mb:34:2:225 · Cited by 236
Dallies, N., François, J., & Paquet, V. (1998) · Yeast · doi:10.1002/(sici)1097-0061(1998100)14:14 · Cited by 236
Kopito, R. R., & Sitia, R. (2000) · EMBO Reports · doi:10.1093/embo-reports/kvd052 · Cited by 234
Eon‐Duval, A., Broly, H., & Gleixner, R. (2012) · Biotechnology Progress · doi:10.1002/btpr.1548 · Cited by 234
Fernández, E. M., Schnell, R., Ranum, L. P. W., Hussey, S. C., Silflow, C. D., & Lefebvre, P. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6449 · Cited by 232
Stability of protein production from recombinant mammalian cells
Barnes, L. M., Bentley, C. M., & Dickson, A. J. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10517 · Cited by 226
Loir, Y. L., Azevedo, V., Oliveira, S. C., Freitas, D., Miyoshi, A., Bermúdez‐Humarán, L. G., Nouaille, S., Ribeiro, L. A., Leclercq, S., Gabriel, J. E., et al. (2005) · Microbial Cell Factories · doi:10.1186/1475-2859-4-2 · Cited by 216
Strain engineering for improved expression of recombinant proteins in bacteria
Makino, T., Σκρέτας, Γ., & Georgiou, G. (2011) · Microbial Cell Factories · doi:10.1186/1475-2859-10-32 · Cited by 207
Therapeutic antibody expression technology
Chadd, H. E., & Chamow, S. M. (2001) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00198-1 · Cited by 205
Large-scale transient expression in mammalian cells for recombinant protein production
Wurm, F. M., & Bernard, A. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)80027-5 · Cited by 205
Serum‐free large‐scale transient transfection of CHO cells
Derouazi, M., Girard, P., Tilborgh, F. V., Iglesias, K., Müller, N., Bertschinger, M., & Wurm, F. M. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20161 · Cited by 205
Engineering of Pichia pastoris for improved production of antibody fragments
Gasser, B., Maurer, M., Gach, J. S., Kunert, R., & Mattanovich, D. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.20851 · Cited by 203
Self-citationTransient gene expression: Recombinant protein production with suspension‐adapted HEK293‐EBNA cells
Meissner, P., Pick, H. M., Kulangara, A., Chatellard, P., Friedrich, K., & Wurm, F. M. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.1179 · Cited by 200
Not just for Eukarya anymore: protein glycosylation in Bacteria and Archaea
Abu‐Qarn, M., Eichler, J., & Sharon, N. (2008) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.06.010 · Cited by 198
Modifications of the metabolic pathways of lipid and triacylglycerol production in microalgae
Yu, W.-L., Ansari, W. S., Schoepp, N. G., Hannon, M. J., Mayfield, S. P., & Burkart, M. D. (2011) · Microbial Cell Factories · doi:10.1186/1475-2859-10-91 · Cited by 198
Development of a GFP reporter gene for Chlamydomonas reinhardtii chloroplast
Franklin, S. E., Ngo, B. X., Efuet, E. T., & Mayfield, S. P. (2002) · The Plant Journal · doi:10.1046/j.1365-313x.2002.01319.x · Cited by 194
Live bacterial vaccines--a review and identification of potential hazards.
Detmer, A. M., & Glenting, J. (2006) · Microbial Cell Factories · doi:10.1186/1475-2859-5-23 · Cited by 191
Strategies for high-level recombinant protein expression in transgenic microalgae: A review
Potvin, G., & Zhang, Z. (2010) · Biotechnology Advances · doi:10.1016/j.biotechadv.2010.08.006 · Cited by 191
Jahic, M., Wållberg, F., Bollók, M., García, P. G. M., & Enfors, S. (2003) · Microbial Cell Factories · doi:10.1186/1475-2859-2-6 · Cited by 190
Synthesis and assembly of a full‐length human monoclonal antibody in algal chloroplasts
Tran, M., Zhou, B., Pettersson, P. L., González, M. J., & Mayfield, S. P. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22446 · Cited by 183
Sinha, J., Plantz, B. A., İnan, M., & Meagher, M. M. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20318 · Cited by 182
Engineering of Therapeutic Proteins Production in Escherichia coli
Kamionka, M. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111794295693 · Cited by 179
Immunogenicity of aggregates of recombinant human growth hormone in mouse models
Fradkin, A. H., Carpenter, J. F., & Randolph, T. W. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21834 · Cited by 173
The Effects of Drugs Inhibiting Protein Secretion in the Filamentous Fungus Trichoderma reesei
Pakula, T., Laxell, M., Huuskonen, A., Uusitalo, J. M., Saloheimo, M., & Penttilä, M. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302372200 · Cited by 171
Self-citationGong, Y., Hu, H., Gao, Y., Xu, X., & Gao, H. C. (2011) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-011-1032-6 · Cited by 168
Nakanishi-Shindo, Y., Nakayama, K.-I., Tanaka, A., Toda, Y., & Jigami, Y. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74320-8 · Cited by 167
Engineering of glycosylation in yeast and other fungi: current state and perspectives
Pourcq, K. D., Schutter, K. D., & Callewaert, N. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2721-1 · Cited by 167
Bench to batch: advances in plant cell culture for producing useful products
Weathers, P. J., Towler, M. J., & Xu, J. (2009) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2354-4 · Cited by 165
Guillemette, T., van Peij, N. N. M. E., Goosen, T., Lanthaler, K., Robson, G. D., van den Hondel, C. A. M. J. J., Stam, H., & Archer, D. B. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-158 · Cited by 158
Damasceno, L. M., Anderson, K. A., Ritter, G., Cregg, J. M., Old, L. J., & Batt, C. A. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0652-7 · Cited by 157
Stadlmayr, G., Mecklenbräuker, A., Rothmüller, M., Maurer, M., Sauer, M., Mattanovich, D., & Gasser, B. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.09.957 · Cited by 155
Self-citationLactococcus lactis as a live vector: Heterologous protein production and DNA delivery systems
Pontes, D. S., de Azevedo, M. S. P., Chatel, J., Langella, P., Azevedo, V., & Miyoshi, A. (2011) · Protein Expression and Purification · doi:10.1016/j.pep.2011.06.005 · Cited by 154
Parkin Accumulation in Aggresomes Due to Proteasome Impairment
Junn, E., Lee, S. S., Suhr, U. T., & Mouradian, M. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203159200 · Cited by 144
Activation mechanisms of the HACI‐mediated unfolded protein response in filamentous fungi
Saloheimo, M., Valkonen, M. J., & Penttilä, M. E. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03363.x · Cited by 144
Self-citationChiba, Y., Suzuki, M., Yoshida, S., Yoshida, A., Ikenaga, H., Takeuchi, M., Jigami, Y., & Ichishima, E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26298 · Cited by 140
Eukaryotic protein production in designed storage organelles
Torrent, M., Llompart, B., Lasserre-Ramassamy, S., Llop-Tous, I., Bastida, M., Marzábal, P., Westerholm‐Parvinen, A., Saloheimo, M., Heifetz, P. B., & Ludevid, M. D. (2009) · BMC Biology · doi:10.1186/1741-7007-7-5 · Cited by 138
Self-citationHarkki, A. M., Uusitalo, J. M., Bailey, M., Penttilä, M. E., & Knowles, J. K. C. (1989) · Nature Biotechnology · doi:10.1038/nbt0689-596 · Cited by 136
Localization of Chaperones DnaK and GroEL in Bacterial Inclusion Bodies
Carrió, M., & Villaverde, A. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.10.3599-3601.2005 · Cited by 136
Self-citationStals, I. (2004) · Glycobiology · doi:10.1093/glycob/cwh080 · Cited by 134
Jørgensen, L., Hostrup, S., Moeller, E. H., & Grohganz, H. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903199143 · Cited by 133
Sohn, S. B., Graf, A. B., Kim, T. Y., Gasser, B., Maurer, M., Ferrer, P., Mattanovich, D., & Lee, S. Y. (2010) · Biotechnology Journal · doi:10.1002/biot.201000078 · Cited by 133
Self-citationJun, H., Kieselbach, T., & Jönsson, L. J. (2011) · Microbial Cell Factories · doi:10.1186/1475-2859-10-68 · Cited by 133
Rattenholl, A., Lilie, H., Grossmann, A., Stern, A., Schwarz, E., & Rudolph, R. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02232.x · Cited by 132
Pham, P. L., Perret, S., Doan, H. C., Cass, B., St‐Laurent, G., Kamen, A., & Durocher, Y. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10774 · Cited by 131
Characterization of the aggregates formed during recombinant protein expression in bacteria
Schrödel, A., & de Marco, A. (2005) · BMC Biochemistry · doi:10.1186/1471-2091-6-10 · Cited by 131
Li, S.-S., & Tsai, H.-J. (2009) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2008.07.004 · Cited by 130
Recombinant protein solubility—does more mean better?
González‐Montalbán, N., García‐Fruitós, E., & Villaverde, A. (2007) · Nature Biotechnology · doi:10.1038/nbt0707-718 · Cited by 130
Self-citationMarx, H., Mecklenbräuker, A., Gasser, B., Sauer, M., & Mattanovich, D. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00561.x · Cited by 127
Self-citationBoehm, R. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1408.009 · Cited by 123
Side effects of chaperone gene co-expression in recombinant protein production
Martínez‐Alonso, M., García‐Fruitós, E., Ferrer‐Miralles, N., Rinas, U., & Villaverde, A. (2010) · Microbial Cell Factories · doi:10.1186/1475-2859-9-64 · Cited by 123
Self-citationEmploying epigenetics to augment the expression of therapeutic proteins in mammalian cells
Kwaks, T., & Otte, A. P. (2006) · Trends in biotechnology · doi:10.1016/j.tibtech.2006.01.007 · Cited by 121
Efficient Production of Antibody Fragments by the Filamentous Fungus Trichoderma reesei
Nyyssönen, E., Penttilä, M. E., Harkki, A. M., Saloheimo, A., Knowles, J. K. C., & Keränen, S. (1993) · Nature Biotechnology · doi:10.1038/nbt0593-591 · Cited by 120
Novel insights into the unfolded protein response using Pichia pastoris specific DNA microarrays
Graf, A. B., Gasser, B., Dragosits, M., Sauer, M., Leparc, G., Tüchler, T., Kreil, D. P., & Mattanovich, D. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-390 · Cited by 117
Self-citationNanostructured bacterial materials for innovative medicines
Rodríguez‐Carmona, E., & Villaverde, A. (2010) · Trends in Microbiology · doi:10.1016/j.tim.2010.06.007 · Cited by 116
Self-citationUse of folding modulators to improve heterologous protein production in Escherichia coli
Kolaj‐Robin, O., Spada, S., Robin, S., & Wall, J. G. (2009) · University of Limerick Institutional Repository (University of Limerick) · doi:10.34961/2685 · Cited by 116
Heterologous Protein Secretion by Bacillus Species
Pohl, S., & Harwood, C. R. (2010) · Advances in applied microbiology · doi:10.1016/s0065-2164(10)73001-x · Cited by 115
100-liter transient transfection
Girard, P., Derouazi, M., Baumgartner, G., Bourgeois, M., Jordan, M., Jacko, B., & Wurm, F. M. (2002) · Cytotechnology · doi:10.1023/a:1021173124640 · Cited by 115
Çelik, E., Çalı́k, P., & Oliver, S. G. (2009) · Yeast · doi:10.1002/yea.1679 · Cited by 115
Production of recombinant proteins and metabolites in yeasts
Porro, D., Gasser, B., Fossati, T., Maurer, M., Branduardi, P., Sauer, M., & Mattanovich, D. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-3019-z · Cited by 112
Self-citationPham, P. L., Perret, S., Cass, B., Carpentier, E., St‐Laurent, G., Bisson, L., Kamen, A., & Durocher, Y. (2005) · Biotechnology and Bioengineering · doi:10.1002/bit.20428 · Cited by 112
Wulhfard, S., Tissot, S., Bouchet, S., Cevey, J., de Jesus, M., Hacker, D. L., & Wurm, F. M. (2008) · Biotechnology Progress · doi:10.1021/bp070286c · Cited by 110
Farid, S. S., Washbrook, J., & Titchener-Hooker, N. J. (2005) · Biotechnology Progress · doi:10.1021/bp049692b · Cited by 109
Current achievements in the production of complex biopharmaceuticals with moss bioreactors
Decker, E. L., & Reski, R. (2007) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-007-0151-y · Cited by 107
Bai, J., Swartz, D. J., Protasevich, I. I., Brouillette, C. G., Harrell, P. M., Hildebrandt, E. F., Gasser, B., Mattanovich, D., Ward, A. B., Chang, G. A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022577 · Cited by 106
Self-citationBöer, E., Steinborn, G., Kunze, G., & Gellissen, G. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-1209-0 · Cited by 105
Barnes, D., Franklin, S. E., Schultz, J., Henry, R. E., Brown, E. C., Coragliotti, A., & Mayfield, S. P. (2005) · Molecular Genetics and Genomics · doi:10.1007/s00438-005-0055-y · Cited by 105
Innocentin, S., Guimarães, V., Miyoshi, A., Azevedo, V., Langella, P., Chatel, J., & Lefèvre, F. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.00825-09 · Cited by 105
E. coli Transports Aggregated Proteins to the Poles by a Specific and Energy-Dependent Process
Rokney, A., Shagan, M., Kessel, M., Smith, Y., Rosenshine, I., & Oppenheim, A. B. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.07.009 · Cited by 104
Analysis of the heat capacity dependence of protein folding
Yang, A., Sharp, K. A., & Honig, B. H. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90229-d · Cited by 102
Gurramkonda, C., Adnan, A., Gäbel, T., Lünsdorf, H., Roß, A., Nemani, S. K., Swaminathan, S., Khanna, N., & Rinas, U. (2009) · Microbial Cell Factories · doi:10.1186/1475-2859-8-13 · Cited by 99
Arvas, M., Pakula, T., Lanthaler, K., Saloheimo, M., Valkonen, M. J., Suortti, T., Robson, G., & Penttilä, M. E. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-32 · Cited by 98
Self-citationSalovuori, I., Makarow, M., Rauvala, H., Knowles, J., & Kääriäinen, L. (1987) · Nature Biotechnology · doi:10.1038/nbt0287-152 · Cited by 98
Enzyme production by recombinant Trichoderma reesei strains
Uusitalo, J. M., Nevalainen, H. K. M., Harkki, A. M., Knowles, J. K. C., & Penttilä, M. E. (1991) · Journal of Biotechnology · doi:10.1016/0168-1656(91)90025-q · Cited by 97
Development of a luciferase reporter gene, luxCt, for Chlamydomonas reinhardtii chloroplast
Mayfield, S. P., & Schultz, J. (2004) · The Plant Journal · doi:10.1046/j.1365-313x.2003.01965.x · Cited by 95
Triggering Aggresome Formation
Zaarur, N., Meriin, A. B., Gabai, V. L., & Sherman, M. Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802216200 · Cited by 95
Piette, F., D’Amico, S., Struvay, C., Mazzucchelli, G., Renaut, J., Tutino, M. L., Danchin, A., Leprince, P., & Feller, G. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07084.x · Cited by 95
Self-citationThe yeast Golgi apparatus: Insights and mysteries
Papanikou, E., & Glick, B. S. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.072 · Cited by 94
Recombinant lactic acid bacteria as mucosal biotherapeutic agents
Daniel, C., Roussel, Y., Kleerebezem, M., & Pot, B. (2011) · Trends in biotechnology · doi:10.1016/j.tibtech.2011.05.002 · Cited by 93
Wang, X., Brandsma, M. E., Tremblay, R., Maxwell, D. P., Jevnikar, A. M., Hüner, N. P. A., & Ma, S. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-87 · Cited by 93
Divergent Genetic Control of Protein Solubility and Conformational Quality in Escherichia coli
García‐Fruitós, E., Martínez‐Alonso, M., González‐Montalbán, N., Valli, M., Mattanovich, D., & Villaverde, A. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.09.004 · Cited by 92
Self-citationBlood–brain barrier delivery of protein and non-viral gene therapeutics with molecular Trojan horses
Pardridge, W. M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.001 · Cited by 92
Lünsdorf, H., Gurramkonda, C., Adnan, A., Khanna, N., & Rinas, U. (2011) · Microbial Cell Factories · doi:10.1186/1475-2859-10-48 · Cited by 92
Moss bioreactors producing improved biopharmaceuticals
Decker, E. L., & Reski, R. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.07.012 · Cited by 92
Recent developments in the production of human therapeutic proteins in eukaryotic algae
Franklin, S. E., & Mayfield, S. P. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.2.225 · Cited by 92
Highly phosphomannosylated enzyme replacement therapy for GM2 gangliosidosis
Tsuji, D., Akeboshi, H., Matsuoka, K., Yasuoka, H., Miyasaki, E., Kasahara, Y., Kawashima, I., Chiba, Y., Jigami, Y., Taki, T., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22262 · Cited by 91
Vaccines based on whole recombinant Saccharomyces cerevisiae cells
Ardiani, A., Higgins, J. P., & Hodge, J. W. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00665.x · Cited by 90
Antibody production with yeasts and filamentous fungi: on the road to large scale?
Gasser, B., & Mattanovich, D. (2006) · Biotechnology Letters · doi:10.1007/s10529-006-9237-x · Cited by 86
Self-citationGriesbeck, C., Kobl, I., & Heitzer, M. (2006) · Molecular Biotechnology · doi:10.1385/mb:34:2:213 · Cited by 85
Food‐grade gene expression in lactic acid bacteria
Peterbauer, C., Maischberger, T., & Haltrich, D. (2011) · Biotechnology Journal · doi:10.1002/biot.201100034 · Cited by 83
Isolation of cell-free bacterial inclusion bodies
Rodríguez‐Carmona, E., Cano‐Garrido, O., Seras‐Franzoso, J., Villaverde, A., & García‐Fruitós, E. (2010) · Microbial Cell Factories · doi:10.1186/1475-2859-9-71 · Cited by 83
Self-citationTutino, M. L., Duilio, A., Parrilli, E., Remaut, E., Sannia, G., & Marino, G. (2001) · Extremophiles · doi:10.1007/s007920100203 · Cited by 82
Self-citationAspartate aminotransferase from the Antarctic bacterium Pseudoalteromonas haloplanktis TAC 125
Birolo, L., Tutino, M. L., Fontanella, B., Gerday, C., Mainolfi, K., Pascarella, S., Sannia, G., Vinci, F., & Marino, G. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01299.x · Cited by 81
Self-citationLiao, Y., Jeng, J., Wang, C., Wang, S., & Chang, S. (2004) · Protein Science · doi:10.1110/ps.04679104 · Cited by 81
Learning about protein solubility from bacterial inclusion bodies
Martínez‐Alonso, M., González‐Montalbán, N., García‐Fruitós, E., & Villaverde, A. (2009) · Microbial Cell Factories · doi:10.1186/1475-2859-8-4 · Cited by 80
Self-citationHigh-Yield Intra- and Extracellular Protein Production Using Bacillus megaterium
Stammen, S., Müller, B. K., Korneli, C., Biedendieck, R., Gamer, M., Franco‐Lara, E., & Jahn, D. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.00431-10 · Cited by 80
Kim, B.-J., Zhou, J., Martin, B., Carlson, O. D., Maudsley, S. R., Greig, N. H., Mattson, M. P., Ladenheim, E. E., Wustner, J., Turner, A., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.166470 · Cited by 78
Inclusion bodies: a new concept
García‐Fruitós, E. (2010) · Microbial Cell Factories · doi:10.1186/1475-2859-9-80 · Cited by 78
Liu, L., Stadheim, A., Hamuro, L., Pittman, T. J., Wang, W., Zha, D., Hochman, J. H., & Prueksaritanont, T. (2011) · Biologicals · doi:10.1016/j.biologicals.2011.06.002 · Cited by 76
Towards universal systems for recombinant gene expression
Sørensen, H. (2010) · Microbial Cell Factories · doi:10.1186/1475-2859-9-27 · Cited by 74
TatABC Overexpression Improves Corynebacterium glutamicum Tat-Dependent Protein Secretion
Kikuchi, Y., Itaya, H., Date, M., Matsui, K., & Wu, L. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.01874-08 · Cited by 72
Advancing mammalian cell culture engineering using genome-scale technologies
Griffin, T. J., Seth, G., Xie, H., Bandhakavi, S., & Hu, W. (2007) · Trends in biotechnology · doi:10.1016/j.tibtech.2007.07.004 · Cited by 71
Recombinant protein vaccines against the asexual blood-stages ofPlasmodium falciparum
Anders, R. F., Adda, C. G., Foley, M., & Norton, R. S. (2010) · Human Vaccines · doi:10.4161/hv.6.1.10712 · Cited by 71
Saloheimo, M., Lund, M., & Penttilä, M. E. (1999) · Molecular and General Genetics MGG · doi:10.1007/s004380051057 · Cited by 68
Self-citationRosser, M. P., Xia, W., Hartsell, S., McCaman, M., Zhu, Y., Wang, S., Harvey, S., Bringmann, P., & Cobb, R. R. (2005) · Protein Expression and Purification · doi:10.1016/j.pep.2004.07.015 · Cited by 68
Glycan Engineering and Production of 'Humanized' Glycoprotein in Yeast Cells
Chiba, Y., & Akeboshi, H. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.786 · Cited by 67
Baumann, K., Adelantado, N., Lang, C., Mattanovich, D., & Ferrer, P. (2011) · Microbial Cell Factories · doi:10.1186/1475-2859-10-93 · Cited by 65
Self-citationNanotechnology, bionanotechnology and microbial cell factories
Villaverde, A. (2010) · Microbial Cell Factories · doi:10.1186/1475-2859-9-53 · Cited by 63
Self-citationKikuchi, Y., Itaya, H., Date, M., Matsui, K., & Wu, L. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-1283-3 · Cited by 62
Systems biology of lactic acid bacteria: a critical review
Teusink, B., Bachmann, H., & Molenaar, D. (2011) · Microbial Cell Factories · doi:10.1186/1475-2859-10-s1-s11 · Cited by 62
Packaging protein drugs as bacterial inclusion bodies for therapeutic applications
Villaverde, A., García‐Fruitós, E., Rinas, U., Seras‐Franzoso, J., Kosoy, A., Corchero, J. L., & Vázquez, E. (2012) · Microbial Cell Factories · doi:10.1186/1475-2859-11-76 · Cited by 61
Self-citationLonger action means better drug: Tuning up protein therapeutics
Szlachcic, A., Zakrzewska, M., & Otlewski, J. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.03.005 · Cited by 61
Xiao, A., Zhou, X., Zhou, L., & Zhang, Y. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0338-1 · Cited by 60
Dragosits, M., Frascotti, G., Bernard‐Granger, L., Vázquez, F., Giuliani, M., Baumann, K., Rodríguez‐Carmona, E., Tokkanen, J., Parrilli, E., Wiebe, M. G., et al. (2011) · Biotechnology Progress · doi:10.1002/btpr.524 · Cited by 59
Self-citationHu, S.-M., Kong, J., Sun, Z., Han, L., Kong, W.-T., & Yang, P. (2011) · Microbial Cell Factories · doi:10.1186/1475-2859-10-86 · Cited by 59
Recombinant Protein Production in Antarctic Gram-Negative Bacteria
Duilio, A., Tutino, M. L., & Marino, G. (2004) · Humana Press eBooks · doi:10.1385/1-59259-774-2:225 · Cited by 59
Self-citationBaumann, K., Dato, L., Graf, A. B., Frascotti, G., Dragosits, M., Porro, D., Mattanovich, D., Ferrer, P., & Branduardi, P. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-218 · Cited by 56
Self-citationHigh-throughput screening and selection of yeast cell lines expressing monoclonal antibodies
Barnard, G. C., Kull, A. R., Sharkey, N., Shaikh, S. S., Rittenhour, A. M., Burnina, I., Jiang, Y., Li, F., Lynaugh, H., Mitchell, T., et al. (2010) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-010-0746-1 · Cited by 55
A new plasmid vector for DNA delivery using lactococci
Guimarães, V., Innocentin, S., Chatel, J., Lefèvre, F., Langella, P., Azevedo, V., & Miyoshi, A. (2009) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-7-4 · Cited by 55
Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris
Freivalds, J., Dišlers, A., Ose, V., Pumpens, P., Tārs, K., & Kazāks, A. (2010) · Protein Expression and Purification · doi:10.1016/j.pep.2010.09.010 · Cited by 55
Pla, I., Damasceno, L. M., Vannelli, T., Ritter, G., Batt, C. A., & Shuler, M. L. (2006) · Biotechnology Progress · doi:10.1021/bp060012+ · Cited by 54
Expression of human soluble TRAIL in Chlamydomonas reinhardtii chloroplast
Yang, Z., Li, Y., Chen, F., Li, D., Zhang, Z., Liu, Y., Zheng, D., Wang, Y., & Shen, G. (2006) · Chinese Science Bulletin · doi:10.1007/s11434-006-2041-0 · Cited by 53
An effective cold inducible expression system developed in Pseudoalteromonas haloplanktis TAC125
Papa, R., Rippa, V., Sannia, G., Marino, G., & Duilio, A. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.07.003 · Cited by 52
Tomlinson, I. M. (2004) · Nature Biotechnology · doi:10.1038/nbt0504-521 · Cited by 51
PK–PD Modeling of Protein Drugs: Implications in Assay Development
Roskos, L. K., Schneider, A. K., Vainshtein, I., Schwickart, M., Lee, R., Lu, H. L., Faggioni, R., & Liang, M. (2011) · Bioanalysis · doi:10.4155/bio.11.28 · Cited by 51
Whyteside, G., Alcocer, M. J. C., Kumita, J. R., Dobson, C. M., Lazarou, M., Pleass, R. J., & Archer, D. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022692 · Cited by 51
Martínez‐Alonso, M., Vera, A., & Villaverde, A. (2007) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2007.00788.x · Cited by 50
Self-citationDevelopment of a generic transient transfection process at 100 L scale
Tuvesson, O., Uhe, C., Rozkov, A., & Lüllau, E. (2008) · Cytotechnology · doi:10.1007/s10616-008-9135-2 · Cited by 50
Chigira, Y., Oka, T., Okajima, T., & Jigami, Y. (2008) · Glycobiology · doi:10.1093/glycob/cwn008 · Cited by 50
Liu, W., Jiang, H., Zhou, J., Yang, X., Tang, Y., Fang, D., & Jiang, L. (2009) · Virus Genes · doi:10.1007/s11262-009-0418-2 · Cited by 49
Formulation Development for Hydrophobic Therapeutic Proteins
Hawe, A., & Frieß, W. (2007) · Pharmaceutical Development and Technology · doi:10.1080/10837450701247350 · Cited by 49
(2011) · Methods in molecular biology · doi:10.1007/978-1-61779-433-9 · Cited by 49
N-Linked glycoengineering for human therapeutic proteins in bacteria
Pandhal, J., & Wright, P. C. (2010) · Biotechnology Letters · doi:10.1007/s10529-010-0289-6 · Cited by 46
Reliable protein production in a Pseudomonas fluorescens expression system
Retallack, D. M., Jin, H., & Chew, L. (2012) · Protein Expression and Purification · doi:10.1016/j.pep.2011.09.010 · Cited by 46
Collén, A., Saloheimo, M., Bailey, M., Penttilä, M. E., & Pakula, T. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20350 · Cited by 46
Self-citationPost-production protein stability: trouble beyond the cell factory
Vázquez, E., Corchero, J. L., & Villaverde, A. (2011) · Microbial Cell Factories · doi:10.1186/1475-2859-10-60 · Cited by 46
Self-citationParrilli, E., Vizio, D. D., Cirulli, C., & Tutino, M. L. (2008) · Microbial Cell Factories · doi:10.1186/1475-2859-7-2 · Cited by 45
Self-citation
Flagged first, then by citations
7 of the 266 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Evans, 2009, Method of controlling O-linked glycosylation of antibodies, Novozymes Biopharm
- Meyer, 2008, An emerging star for therapeutic and catalytic protein production, BioProcess Int, 6, 10
Cited by
Sorted by citations
Adaptive laboratory evolution—Principles and applications for biotechnology
Dragosits, M., & Mattanovich, D. (2013) · Microbial Cell Factories · doi:10.1186/1475-2859-12-64 · Cited by 827
Self-citationRecombinant pharmaceuticals from microbial cells: a 2015 update
Sánchez‐García, L., Martín, L., Mangues, R., Ferrer‐Miralles, N., Vázquez, E., & Villaverde, A. (2016) · Microbial Cell Factories · doi:10.1186/s12934-016-0437-3 · Cited by 341
Self-citationRasala, B. A., & Mayfield, S. P. (2014) · Photosynthesis Research · doi:10.1007/s11120-014-9994-7 · Cited by 296
The Potential for Microalgae as Bioreactors to Produce Pharmaceuticals
Yan, N. J., Fan, C., Chen, Y., & Hu, Z. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060962 · Cited by 264
Pichia Pastoris : Protein Production Host and Model Organism for Biomedical Research
Gasser, B., Prielhofer, R., Marx, H., Maurer, M., Nocon, J., Steiger, M. G., Puxbaum, V., Sauer, M., & Mattanovich, D. (2013) · Future Microbiology · doi:10.2217/fmb.12.133 · Cited by 237
Self-citation
Metadata
- Authors
- Corchero, J. L., Gasser, B., Resina, D., Smith, W., Parrilli, E., Vázquez, F., Abasolo, I., Giuliani, M., Jäntti, J., Ferrer, P., Saloheimo, M., Mattanovich, D., Schwartz, S., Tutino, M. L., & Villaverde, A.
- Affiliations
- Austrian Centre of Industrial Biotechnology (Austria) (AT)
- Parc Científic de Barcelona (ES)
- VTT Technical Research Centre of Finland (FI)
- University of Naples Federico II (IT)
- Universitat Autònoma de Barcelona (ES)
- Corresponding author
- Villaverde, Antonio
- ORCID
- Venue
- Biotechnology Advances
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 31
- Issue
- 2
- Pages
- 140-153
- ISSN
- 0734-9750 (ISSN-L)
- OpenAlex
- W2069940872
- Cited by
- 133
- References
- 266
- Citations by year
- 2026: 8 · 2025: 4 · 2024: 6 · 2023: 6 · 2022: 10 · 2021: 7 · 2020: 6 · 2019: 8 · 2018: 3 · 2017: 11 · 2016: 20 · 2015: 14 · 2014: 17 · 2013: 11
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biotechnology Advances (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institució Catalana de Recerca i Estudis Avançats
- Steirische Wirtschaftsförderungsgesellschaft
- Instituto de Salud Carlos III
- European Regional Development Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial Metabolic Engineering and Bioproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- therapeutic proteins, recombinant protein expression, microbial cell factories, post-translational modification, intracellular retention, recombinant yeast, recombinant bacteria
- MeSH terms
- Animals, Cost-Benefit Analysis, Escherichia coli, Industrial Microbiology, Mammals, Pichia, Protein Processing, Post-Translational, Recombinant Proteins, Saccharomyces cerevisiae, Trichoderma, Protein Engineering, Chlamydomonas reinhardtii, Protein Folding, Pseudoalteromonas
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review